P21-Activated Kinase 2 抗体
(P21-Activated Kinase 2 (PAK2))
The p21 activated kinases (PAK) are critical effectors that link Rho GTPases to cytoskeleton reorganization and nuclear signaling. The PAK proteins are a family of serine/threonine kinases that serve as targets for the small GTP binding proteins, CDC42 and RAC1, and have been implicated in a wide range of biological activities. The protein encoded by this gene is activated by proteolytic cleavage during caspase-mediated apoptosis, and may play a role in regulating the apoptotic events in the dying cell. [provided by RefSeq, Jul 2008].
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| PAK2 抗体 (AA 177-419) | 人 | 兔 Polyclonal |
|
|
|
| PAK2 抗体 (pSer141) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| PAK2 抗体 (pSer20) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| PAK2 抗体 (pSer192) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| PAK2 抗体 | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| PAK2 抗体 (pSer197) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| PAK2 抗体 (AA 192-222) (FITC) | 人 | 兔 Polyclonal |
|
|
|
| PAK2 抗体 (AA 192-222) (HRP) | 人 | 兔 Polyclonal |
|
|
|
| PAK2 抗体 (AA 192-222) (PE) | 人 | 兔 Polyclonal |
|
|
|
| PAK2 抗体 (AA 192-222) (Biotin) | 人 | 兔 Polyclonal |
|
|
|
| PAK2 抗体 (AA 192-222) (APC) | 人 | 兔 Polyclonal |
|
|
|
| PAK2 抗体 (AA 192-222) | 人 | 兔 Polyclonal |
|
|
|
| PAK2 抗体 (N-Term) | 人, 小鼠, 大鼠, 猴, 豚鼠 | 兔 Polyclonal |
|
|
|
| PAK2 抗体 (C-Term) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| PAK2 抗体 (N-Term) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| PAK2 抗体 (AA 1-212) | 人 | 兔 Polyclonal |
|
|
|
| PAK2 抗体 (AA 25-75) | 人, 小鼠 | 兔 Polyclonal |
|
|
|
| PAK2 抗体 (AA 125-175) | 人 | 兔 Polyclonal |
|
|
|
| PAK2 抗体 (pSer192) | 人 | 兔 Polyclonal |
|
|
|
| PAK2 抗体 (pSer141) | 人 | 兔 Polyclonal |
|
|
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 177-419
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- pSer141
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- pSer20
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- pSer192
Primary Antibody
- ELISA (ELISA: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- pSer197
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- FITC
- 抗体亚型
- IgG
- 抗原表位
- AA 192-222
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- HRP
- 抗体亚型
- IgG
- 抗原表位
- AA 192-222
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- PE
- 抗体亚型
- IgG
- 抗原表位
- AA 192-222
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Biotin
- 抗体亚型
- IgG
- 抗原表位
- AA 192-222
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- APC
- 抗体亚型
- IgG
- 抗原表位
- AA 192-222
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 192-222
Primary Antibody
- WB (Western Blotting: 所列应用)
- IP (Immunoprecipitation: 所列应用)
- 适用
- 人, 小鼠, 大鼠, 猴, 豚鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- N-Term
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- IF (Immunofluorescence: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 440-490, C-Term
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- IF (Immunofluorescence: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 20-70, N-Term
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
KO 验证
- 质量等级
- KO Validated
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 1-212
Primary Antibody
- WB (Western Blotting: 所列应用)
- IP (Immunoprecipitation: 所列应用)
- 适用
- 人, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 25-75
Primary Antibody
- WB (Western Blotting: 所列应用)
- IP (Immunoprecipitation: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 125-175
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- pSer192
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- pSer141
Latest Publications for our P21-Activated Kinase 2 抗体
: "P21-activated kinase 2 is essential in maintenance of peripheral Foxp3+ regulatory T cells." in: Immunology, Vol. 154, Issue 2, pp. 309-321, (2018) (PubMed).
: "Pak2 is required for actin cytoskeleton remodeling, TCR signaling, and normal thymocyte development and maturation." in: eLife, Vol. 3, pp. e02270, (2015) (PubMed).
: "Label-free quantitative phosphoproteomic analysis reveals differentially regulated proteins and pathway in PRRSV-infected pulmonary alveolar macrophages." in: Journal of proteome research, Vol. 13, Issue 3, pp. 1270-80, (2014) (PubMed).
: "Phosphorylation of NLRC4 is critical for inflammasome activation." in: Nature, Vol. 490, Issue 7421, pp. 539-42, (2012) (PubMed).
: "c-Abl-binding protein interacts with p21-activated kinase 2 (PAK-2) to regulate PDGF-induced membrane ruffles." in: Journal of molecular biology, Vol. 370, Issue 4, pp. 620-32, (2007) (PubMed).
: "Posttranslational myristoylation of caspase-activated p21-activated protein kinase 2 (PAK2) potentiates late apoptotic events." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 103, Issue 17, pp. 6542-7, (2006) (PubMed).
: "A novel role for p21-activated protein kinase 2 in T cell activation." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 172, Issue 12, pp. 7324-34, (2004) (PubMed).
: "The mental retardation protein PAK3 contributes to synapse formation and plasticity in hippocampus." in: The Journal of neuroscience : the official journal of the Society for Neuroscience, Vol. 24, Issue 48, pp. 10816-25, (2004) (PubMed).
: "Caspase-activated PAK-2 is regulated by subcellular targeting and proteasomal degradation." in: The Journal of biological chemistry, Vol. 278, Issue 40, pp. 38675-85, (2003) (PubMed).
: "p21-activated kinases: three more join the Pak." in: The international journal of biochemistry & cell biology, Vol. 34, Issue 7, pp. 713-7, (2002) (PubMed).
: "Pak2 is required for actin cytoskeleton remodeling, TCR signaling, and normal thymocyte development and maturation." in: eLife, Vol. 3, pp. e02270, (2015) (PubMed).
: "Label-free quantitative phosphoproteomic analysis reveals differentially regulated proteins and pathway in PRRSV-infected pulmonary alveolar macrophages." in: Journal of proteome research, Vol. 13, Issue 3, pp. 1270-80, (2014) (PubMed).
: "Phosphorylation of NLRC4 is critical for inflammasome activation." in: Nature, Vol. 490, Issue 7421, pp. 539-42, (2012) (PubMed).
: "c-Abl-binding protein interacts with p21-activated kinase 2 (PAK-2) to regulate PDGF-induced membrane ruffles." in: Journal of molecular biology, Vol. 370, Issue 4, pp. 620-32, (2007) (PubMed).
: "Posttranslational myristoylation of caspase-activated p21-activated protein kinase 2 (PAK2) potentiates late apoptotic events." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 103, Issue 17, pp. 6542-7, (2006) (PubMed).
: "A novel role for p21-activated protein kinase 2 in T cell activation." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 172, Issue 12, pp. 7324-34, (2004) (PubMed).
: "The mental retardation protein PAK3 contributes to synapse formation and plasticity in hippocampus." in: The Journal of neuroscience : the official journal of the Society for Neuroscience, Vol. 24, Issue 48, pp. 10816-25, (2004) (PubMed).
: "Caspase-activated PAK-2 is regulated by subcellular targeting and proteasomal degradation." in: The Journal of biological chemistry, Vol. 278, Issue 40, pp. 38675-85, (2003) (PubMed).
: "p21-activated kinases: three more join the Pak." in: The international journal of biochemistry & cell biology, Vol. 34, Issue 7, pp. 713-7, (2002) (PubMed).
Aliases for P21-Activated Kinase 2 抗体
p21 (RAC1) activated kinase 2 (PAK2) 抗体p21 protein (Cdc42/Rac)-activated kinase 2 (Pak2) 抗体
p21 protein (Cdc42/Rac)-activated kinase 2a (pak2a) 抗体
p21 protein (Cdc42/Rac)-activated kinase 2 S homeolog (pak2.S) 抗体
p21 (RAC1) activated kinase 2 (Pak2) 抗体
p21 protein (Cdc42/Rac)-activated kinase 2b (pak2b) 抗体
5330420P17Rik 抗体
A130002K10Rik 抗体
AI836325 抗体
cb422 抗体
CH73-159L23.1 抗体
D16Ertd269e 抗体
gamma-PAK 抗体
kinase 抗体
mKIAA4182 抗体
PAK-2 抗体
pak2 抗体
Pak3 抗体
PAK65 抗体
pak65 抗体
PAKgamma 抗体
pakgamma 抗体
PAKI 抗体
si:dz198m22.1 抗体
wu:fb71h01 抗体
wu:fc52b03 抗体
zgc:91798 抗体
zgc:113857 抗体
您还需要查找其他产品吗？
You are here:
